| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diarrhea | D003967 | 32 associated lipids |
| Pain | D010146 | 64 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Fractures, Spontaneous | D005598 | 4 associated lipids |
| Osteomyelitis | D010019 | 10 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Intraoperative Complications | D007431 | 5 associated lipids |
| Drug Hypersensitivity | D004342 | 20 associated lipids |
| Hyperbilirubinemia | D006932 | 11 associated lipids |
| Anaphylaxis | D000707 | 35 associated lipids |
Rifamycin SV
Rifamycin SV is a lipid of Polyketides (PK) class. Rifamycin sv is associated with abnormalities such as Cholestasis, Infection, Dysentery, Soft Tissue Infections and Osteomyelitis. The involved functions are known as Uptake, Excretory function, Drug Kinetics, inhibitors and anaphylaxis. Rifamycin sv often locates in Hepatic, Blood, soluble, Entire gastrointestinal tract and Membrane. The associated genes with Rifamycin SV are SLCO1C1 gene, SLCO1B1 gene, ABCB11 gene and SLC10A1 gene.
Cross Reference
Introduction
To understand associated biological information of Rifamycin SV, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Rifamycin SV?
Rifamycin SV is suspected in Tuberculosis, Cholestasis, Infection, Dysentery, Soft Tissue Infections, Osteomyelitis and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Rifamycin SV
PubChem Associated disorders and diseases
What pathways are associated with Rifamycin SV
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Rifamycin SV?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Rifamycin SV?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Rifamycin SV?
There are no associated biomedical information in the current reference collection.
What genes are associated with Rifamycin SV?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Rifamycin SV?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Rifamycin SV
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Spisani S et al. | 3-(Carboxyalkylthio) rifamycin S and SV derivatives inhibit human neutrophil functions. | 1998 | Inflammation | pmid:9793793 |
| Erel F et al. | Severe anaphylaxis from rifamycin SV. | 1998 | Ann. Allergy Asthma Immunol. | pmid:9759804 |
| Crance JM et al. | Inhibition of sandfly fever Sicilian virus (Phlebovirus) replication in vitro by antiviral compounds. | 1997 Sep-Oct | Res. Virol. | pmid:9403935 |
| González CI et al. | Reverse transcriptase-like activity in Trypanosoma cruzi. | 1997 | Acta Trop. | pmid:9088425 |
| Chiao JS et al. | Rifamycin SV and related ansamycins. | 1995 | Biotechnology | pmid:8688635 |
| Abu-Shady MR et al. | Studies of rifamycin production by Amycolatopsis mediterranei cells immobilized on glass wool. | 1995 | J. Basic Microbiol. | pmid:8568638 |
| Ward TJ et al. | Enantiomeric resolution using the macrocyclic antibiotics rifamycin B and rifamycin SV as chiral selectors for capillary electrophoresis. | 1995 | J Chromatogr A | pmid:8520671 |
| Marchesoni A et al. | Rifamycin SV versus triamcinolone in local treatment of rheumatoid synovitis. | 1993 | Scand. J. Rheumatol. | pmid:8356413 |
| Sáez GT et al. | The role of glutathione in protection against DNA damage induced by rifamycin SV and copper(II) ions. | 1993 | Free Radic. Res. Commun. | pmid:8225041 |
| Caruso I et al. | Rifamycin SV administered by intra-articular infiltrations shows disease modifying activity in patients with pauci- or polyarticular juvenile rheumatoid arthritis. | 1993 Sep-Oct | J. Int. Med. Res. | pmid:8112482 |
| Persico M et al. | The association between rifamycin-SV (R-SV) related hyperbilirubinaemia and antipyrine clearance as a new test of liver function in cirrhosis. | 1994 | Eur. J. Clin. Invest. | pmid:8033955 |
| Fardel O et al. | Rifampicin enhances anti-cancer drug accumulation and activity in multidrug-resistant cells. | 1995 | Biochem. Pharmacol. | pmid:7763306 |
| Muñiz P et al. | The role of 8-hydroxy-2'-deoxyguanosine in rifamycin-induced DNA damage. | 1995 | Free Radic. Biol. Med. | pmid:7750799 |
| Kukiełka E and Cederbaum AI | Stimulation of NADH-dependent microsomal DNA strand cleavage by rifamycin SV. | 1995 | Biochem. J. | pmid:7733870 |
| Cardot E et al. | Anaphylactic reaction to local administration of rifamycin SV. | 1995 | J. Allergy Clin. Immunol. | pmid:7529781 |
| Okolicsanyi L et al. | Influence of rifamycin SV on bile acid metabolism in rats. | 1980 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:7422017 |
| Bellomo P et al. | Synthesis and antibacterial activity of some ester, amides, and hydrazides of 3-carboxyrifamycin S. Relationship between structure and activity of ansamycins. | 1981 | J. Med. Chem. | pmid:7310806 |
| Xiao-Chang F and Naganawa H | 1H NMR analysis of R-75-1 substance. | 1981 | Jpn J Antibiot | pmid:7289042 |
| Spisani S et al. | [Effect of rifamycin SV on neutrophil functions in patients with rheumatoid arthritis]. | 1981 | Boll. Soc. Ital. Biol. Sper. | pmid:7236419 |
| Ghisalba O et al. | Transformation of rifamycin S into rifamycins B and L. A revision of the current biosynthetic hypothesis. | 1982 | J. Antibiot. | pmid:7200089 |
| Fernandes D and Giacinti F | [Agranulocytosis induced by rifamycin SV in a patient with Hodgkin's disease. Immunologic considerations and pathogenetic interpretations]. | 1982 Jan-Jun | G Batteriol Virol Immunol | pmid:7187341 |
| Kono Y | Aerobic oxidation of rifamycin SV to rifamycin S catalyzed by horseradish peroxidase. | 1982 | J. Biochem. | pmid:7096316 |
| Spisani S et al. | The effect of rifamycin SV on neutrophil functions in patients with rheumatoid arthritis. | 1982 | Scand. J. Rheumatol. | pmid:7089503 |
| Cottafava F et al. | [Rheumatoid synovitis of the knee, treated successfully with intra-articular rifamycin SV]. | 1982 | Minerva Pediatr. | pmid:7070359 |
| Quinn FR | The quantitative structure-activity relationship of rifamycin B amide and hydrazide toxicity in mice. | 1982 | Farmaco Sci | pmid:7056391 |
| Caruso I et al. | Rheumatoid knee synovitis successfully treated with intra-articular rifamycin SV. | 1982 | Ann. Rheum. Dis. | pmid:7046652 |
| Karaivanov L et al. | [Attempt at eliminating the multiple drug resistance of E. coli in pigs with enteritis using Rimactin]. | 1980 | Vet Med Nauki | pmid:7015689 |
| Bruni L et al. | Preliminary results of a clinical trial relative to the use of rifamycin SV in the treatment of herpes zoster. | 1980 | J. Int. Med. Res. | pmid:6987112 |
| Arora SK | Correlation of structure and activity in ansamycins. Molecular structure of sodium rifamycin SV. | 1983 | Mol. Pharmacol. | pmid:6865897 |
| Nikiforov VG et al. | A derivative of rifamycin SV inhibiting rifampicin-resistant RNA polymerase of Escherichia coli. | 1982 | FEBS Lett. | pmid:6761147 |
| Gentile S et al. | Plasma clearance of nicotinic acid and rifamycin-SV, and their interaction in Gilbert's syndrome: application of a compartmental model. | 1984 | Hepatogastroenterology | pmid:6724499 |
| Dekio S and Jidoi J | Mechanism of coagulase production in Staphylococcus aureus Smith. | 1983 | Zentralbl Bakteriol Mikrobiol Hyg A | pmid:6673416 |
| Vogt E | [Effects of rifamycin SV and a neomycin-bacitracin combination on the healing of microbial eczema]. | 1983 | Z. Hautkr. | pmid:6649743 |
| Craven N and Anderson JC | Antibiotic activity against intraleukocytic Staphylococcus aureus in vitro and in experimental mastitis in mice. | 1983 | Am. J. Vet. Res. | pmid:6553464 |
| Brufani M et al. | The synthesis of 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives. | 1984 | J. Antibiot. | pmid:6526730 |
| Deshko TN et al. | [Physico-chemical properties of DNA-dependent RNA-polymerase from Escherichia coli and its subunits]. | 1984 | Bioorg. Khim. | pmid:6388581 |
| Bruni L et al. | Herpes zoster treatments: results of a clinical trial relative to the use of rifamycin SV versus neuramide. | 1984 | J. Int. Med. Res. | pmid:6381169 |
| Freymuth F et al. | [In vitro activity of rifamycin SV on herpes simplex and herpes varicella viruses]. | 1983 May-Jun | Therapie | pmid:6310814 |
| Păunescu E et al. | [Preliminary results of the use of a new derivative of rifamycin SV in the treatment of sarcoidosis]. | 1982 Apr-Jun | Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol | pmid:6294806 |
| Kono Y and Sugiura Y | Electron spin resonance studies on the oxidation of rifamycin SV catalyzed by metal ions. | 1982 | J. Biochem. | pmid:6279586 |
| Kono Y | Oxygen Enhancement of bactericidal activity of rifamycin SV on Escherichia coli and aerobic oxidation of rifamycin SV to rifamycin S catalyzed by manganous ions: the role of superoxide. | 1982 | J. Biochem. | pmid:6279585 |
| Amagai T et al. | The effect of ribavirin and rifamycin SV on age-dependent changes of the immune system during the adult life of SJL mice. | 1982 | Immunol. Lett. | pmid:6210629 |
| Revuz J et al. | [Generalization of zona in a nonimmunosuppressed patient receiving isoprinosine and rifamycin SV]. | 1983 | Ann Dermatol Venereol | pmid:6195953 |
| Xiao-Chang F et al. | Biochemical study of R-75-1, a new semi-synthetic rifamycin. | 1981 | J. Antibiot. | pmid:6168632 |
| Kradolfer F et al. | Chemotherapeutic activity of new derivatives of rifamycin. | 1966 | Antimicrob Agents Chemother (Bethesda) | pmid:5985258 |
| Okolicsanyi L et al. | [Effect of rifamycin SV on the metabolism of bile salts in the rat]. | 1979 Jan-Dec | G Ital Chemioter | pmid:554815 |
| Marchi E et al. | [New derivatives of rifamycin SV. Esters, hydrazide amides of 3-carboxyrifamycin SV]. | 1979 Jan-Dec | G Ital Chemioter | pmid:554811 |
| Gentile S et al. | [Influence of allopurinol on the half-life of tolbutamide and rifamycin-SV in blood of healthy volunteers]. | 1979 | Boll. Soc. Ital. Biol. Sper. | pmid:552849 |
| Nitti V | The antituberculous activity of rifamycin SV. | 1965 | Helv Med Acta | pmid:4958120 |
| Maggi N et al. | New derivatives of rifamycin SV. | 1965 | Antimicrob Agents Chemother (Bethesda) | pmid:4956802 |
| Kenwright S and Levi AJ | Sites of competition in the selective hepatic uptake of rifamycin-SV, flavaspidic acid, bilirubin, and bromsulphthalein. | 1974 | Gut | pmid:4842968 |
| Erickson RJ and Grosch JC | Isolation and characterization of a polynucleotide phosphorylase from Bacillus amyloliquefaciens. | 1977 | J. Bacteriol. | pmid:45489 |
| Cricchio R and Tamborini G | A new series of semisynthetic rifamycins. N derivatives of 4-amino-4-deoxyrifamycin SV. | 1971 | J. Med. Chem. | pmid:4398855 |
| Medoff G et al. | Potentiation of rifampicin, rifampicin analogs, and tetracycline against animal cells by amphotericin B and polymyxin B. | 1973 | Cancer Res. | pmid:4352361 |
| Lindblad S et al. | Rifamycin SV in local treatment of synovitis--a clinical, arthroscopic and pharmacologic evaluation. | 1985 | J. Rheumatol. | pmid:4087269 |
| Gentile S et al. | Impaired plasma clearance of nicotinic acid and rifamycin-SV in Gilbert's syndrome: evidence of a functional heterogeneity. | 1985 | Hepatogastroenterology | pmid:4018705 |
| Babasaki K et al. | Subtilosin A, a new antibiotic peptide produced by Bacillus subtilis 168: isolation, structural analysis, and biogenesis. | 1985 | J. Biochem. | pmid:3936839 |
| Furet Y et al. | [Mixed hepatitis due to rifamycin SV. Apropos of a case]. | 1986 Sep-Oct | Therapie | pmid:3810533 |
| Yu WH et al. | [Study of incompatibility in vitro of injection of rifamycin sodium with 45 injections]. | 1986 | Hua Xi Yi Ke Da Xue Xue Bao | pmid:3804311 |
| Caruso I | Rifamycin SV in the local treatment of synovitis. | 1987 | J. Rheumatol. | pmid:3572924 |
| Passamonti S and Sottocasa GL | The quinoid structure is the molecular requirement for recognition of phthaleins by the organic anion carrier at the sinusoidal plasma membrane level in the liver. | 1988 | Biochim. Biophys. Acta | pmid:3401473 |
| Hanzlik J et al. | [Clinical evaluation of rifamycin SV in ampules of 250 and 500 mg produced by the Tarchomin Pharmaceutical Plants "Polfa"]. | 1986 | Ann Univ Mariae Curie Sklodowska Med | pmid:3154057 |
| Gao DZ | [Determination of rifampin, rifamdin and rifocin concentrations in the CSF of 71 patients with tuberculous meningitis]. | 1986 | Zhonghua Yi Xue Za Zhi | pmid:3094900 |
| Testa A et al. | Preclinical Evaluation of [F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transporters. | 2018 | Contrast Media Mol Imaging | pmid:30154685 |
| Zhang Y et al. | GlnR positive transcriptional regulation of the phosphate-specific transport system pstSCAB in Amycolatopsis mediterranei U32. | 2018 | Acta Biochim. Biophys. Sin. (Shanghai) | pmid:30007316 |
| Qi F et al. | Deciphering the late steps of rifamycin biosynthesis. | 2018 | Nat Commun | pmid:29904078 |
| Lin SW et al. | Rifamycin SV MMX for the treatment of traveler's diarrhea. | 2017 | Expert Opin Pharmacother | pmid:28697313 |
| Narang SS et al. | Molecular insights into the inhibitory mechanism of rifamycin SV against β-microglobulin aggregation: A molecular dynamics simulation study. | 2017 | Int. J. Biol. Macromol. | pmid:28455257 |
| Quinlan GJ and Gutteridge JM | Oxygen radical damage to DNA by rifamycin SV and copper ions. | 1987 | Biochem. Pharmacol. | pmid:2823829 |
| Bi YA et al. | Reliable Rate Measurements for Active and Passive Hepatic Uptake Using Plated Human Hepatocytes. | 2017 | AAPS J | pmid:28188574 |
| Vékey K et al. | Liquid chromatographic-mass spectrometric studies on rifamycin antibiotics. | 1989 | J. Chromatogr. | pmid:2768398 |
| Alsdurf H et al. | The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. | 2016 | Lancet Infect Dis | pmid:27522233 |
| Sayyed K et al. | Alteration of human hepatic drug transporter activity and expression by cigarette smoke condensate. | 2016 | Toxicology | pmid:27450509 |
| Li Q et al. | [Ocular syndromes in patients with neurobrucellosis]. | 2015 | Zhonghua Yan Ke Za Zhi | pmid:26888270 |
| Li W et al. | Development of a sensitive and rapid method for rifampicin impurity analysis using supercritical fluid chromatography. | 2015 | J Pharm Biomed Anal | pmid:26103526 |
| Shao ZH et al. | A preliminary study of the mechanism of nitrate-stimulated remarkable increase of rifamycin production in Amycolatopsis mediterranei U32 by RNA-seq. | 2015 | Microb. Cell Fact. | pmid:26041361 |
| Nagavalli M et al. | Enhanced rifamycin SV production by submerged fermentation using Amycolatopsis mediterranei. | 2015 | Appl. Microbiol. Biotechnol. | pmid:26026938 |
| Michelson AM | Pro-oxidant action of superoxide dismutase in the autoxidation of rifamycin SV. | 1986 | Free Radic. Res. Commun. | pmid:2577735 |
| Pyta K et al. | Regioselective long-range proton transfer in new rifamycin antibiotics: a process in which crown ethers act as stronger Brønsted bases than amines. | 2015 | Chemphyschem | pmid:25639734 |
| Torbeev V et al. | Substitution of proline32 by α-methylproline preorganizes β2-microglobulin for oligomerization but not for aggregation into amyloids. | 2015 | J. Am. Chem. Soc. | pmid:25633201 |
| Kenny MT et al. | Comparative effect of the naphthalenic ansamycins rifamycin SV, rifampin and cyclopentylrifampicin on murine neutrophil function. | 1989 | Int. J. Immunopharmacol. | pmid:2559042 |
| Sha W | [How to use rifamycin rationally: the key issue to prevent multidrug-resistant tuberculosis]. | 2014 | Zhonghua Jie He He Hu Xi Za Zhi | pmid:25537407 |
| Nagavalli M et al. | Solid state fermentation and production of rifamycin SV using Amycolatopsis mediterranei. | 2015 | Lett. Appl. Microbiol. | pmid:25256628 |
| Kawde AN et al. | Adsorptive stripping voltammetry of antibiotics rifamycin SV and rifampicin at renewable pencil electrodes. | 2014 | Acta Chim Slov | pmid:25125124 |
| Gentile S et al. | The implication of bilitranslocase function in the impaired rifamycin SV metabolism in Gilbert's syndrome. | 1985 | Clin. Sci. | pmid:2485269 |
| Aygün F et al. | The protective effect of topical rifamycin treatment against sternal wound infection in diabetic patients undergoing on-pump coronary artery bypass graft surgery. | 2014 May-Jun | Cardiovasc J Afr | pmid:24687038 |
| Evans SE et al. | The ansamycin antibiotic, rifamycin SV, inhibits BCL6 transcriptional repression and forms a complex with the BCL6-BTB/POZ domain. | 2014 | PLoS ONE | pmid:24595451 |
| Wondrak EM et al. | Inhibition of HIV-1 RNA-dependent DNA polymerase and cellular DNA polymerases alpha, beta and gamma by phosphonoformic acid and other drugs. | 1988 | J. Antimicrob. Chemother. | pmid:2452149 |
| Dechert-Schmitt AM et al. | Polyketide construction via hydrohydroxyalkylation and related alcohol C-H functionalizations: reinventing the chemistry of carbonyl addition. | 2014 | Nat Prod Rep | pmid:24514754 |
| Przybylski P et al. | 13C and 15N CP/MAS, 1H-15N SCT CP/MAS and FTIR spectroscopy as tools for qualitative detection of the presence of zwitterionic and non-ionic forms of ansa-macrolide 3-formylrifamycin SV and its derivatives in solid state. | 2014 Jan-Feb | Magn Reson Chem | pmid:24347399 |
| Chiou WJ et al. | In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia. | 2014 | Xenobiotica | pmid:23886114 |
| Rosette C et al. | Anti-inflammatory and immunomodulatory activities of rifamycin SV. | 2013 | Int. J. Antimicrob. Agents | pmid:23756321 |
| Gurel MS et al. | Comparison of the effects of topical fusidic acid and rifamycin on wound healing in rats. | 2015 | Int Wound J | pmid:23489386 |
| Kumar S et al. | Synthesis and biological evaluation of trans 6-methoxy-1,1-dimethyl-2-phenyl-3-aryl-2,3-dihydro-1H-inden-4-yloxyalkylamine derivatives against drug susceptible, non-replicating M. tuberculosis H37Rv and clinical multidrug resistant strains. | 2013 | Bioorg. Med. Chem. Lett. | pmid:23474387 |
| Iselin F et al. | [Comparative study of the effects of a local antibiotic and a local antiseptic in emergency hand surgery]. | 1990 | Ann Chir Main Memb Super | pmid:2346354 |
| Cavalleri B et al. | Synthesis and biological activity of some derivatives of rifamycin P. | 1990 | J. Med. Chem. | pmid:2329569 |
| Singh R et al. | No impact of rifamycin selection on tuberculosis treatment outcome in HIV coinfected patients. | 2013 | AIDS | pmid:23014518 |
| Traxler P et al. | Hypolipidemic activity of rifamycin derivatives. | 1990 | J. Med. Chem. | pmid:2299623 |
| Calatayud M et al. | In vitro study of transporters involved in intestinal absorption of inorganic arsenic. | 2012 | Chem. Res. Toxicol. | pmid:22214486 |
| Falkinham JO et al. | Antibacterial activities of dendritic amphiphiles against nontuberculous mycobacteria. | 2012 | Tuberculosis (Edinb) | pmid:22209468 |